In the recent decade, nanoparticles (NPs) have had enormous implications in cancer
biomedicine, including research, diagnosis, and therapy. However, their broad application …

Nanomedicine has gained much attention for the management and treatment of cancers due
to the distinctive physicochemical properties of the drug‐loaded particles. Chitosan's …

Cancer poses a significant global health threat, with millions of new cases and deaths
annually reported. The traditional chemotherapy faces challenges due to poor drug …

Cancer is a complex disease with second leading cause of mortality all over the world.
According to WHO, cancer-related deaths are projected to increase to∼ 13.1 million by …

With exponential growth in nanotechnology and material chemistry, the application of a
variety of nanomaterials in biomedical field has attracted increasing interest, especially in …

Chitosan is cancer cytotoxic. It induces apoptosis/necrosis/autophagy and immuno-
responses, and mitigates angiogenic and metastasis tendency of cancer cells. The lower …

Chitosan is an excellent biopolymer, widely used in drug delivery. Chitosan is a bio-
compatible and biodegradable polysaccharide that is derived from chitin. It can be used in …

Chitosan has attracted considerable attention as an anti-tumor drug carrier material in recent
years, which is due to its biocompatibility and biodegradability, as well as the simple and …

In recent years, many nanotechnology platforms in the area of medical biology, including
cancer therapy, have attracted remarkable attention. In particular, research in targeted …

Currently, cancer is the leading cause of death globally. In the absence of specific treatment
and early diagnosis, procedures like surgery, chemotherapy, and radiation therapy are often …